logo
Plus   Neg
Share
Email

Sandoz To Appeal U.S. Court Ruling In Biosimilar Erelzi U.S. Patent Case

Sandoz, a Novartis division (NVS), said that the United States District Court of New Jersey ruled against Sandoz in patent litigation regarding the Sandoz biosimilar, Erelzi or etanercept-szzs for reference medicine Enbrel or etanercept. The company will appeal the ruling to the U.S. Court of Appeals for the Federal Circuit, and the parties have agreed to an expedited appeal.

Sandoz said it disagreed with the Court's ruling, which prevents the company from launching an additional treatment option for patients with autoimmune and inflammatory diseases. It continues to consider the patents in this case to be invalid.

According to Sandoz, Amgen asserted two patents that it obtained from Roche, in what Sandoz believes is an attempt to extend its US compound patent protection for etanercept to 2029.oz said, "We will appeal this decision, and look forward to presenting our case to the Federal Circuit and bringing Erelzi to US patients as soon as possible."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Commerzbank AG (CRZBY.PK) said Friday that it plans to cut 4,300 jobs, as part of its strategy. It also plans to sell its majority stake in mbank S.A. It is considering making a purchase offer to Comdirect's outstanding shareholders. Walmart, which has said its goal is to become America's neighborhood health destination, is hosting a free wellness event in its stores across the country on Saturday, September 21. The "Walmart Wellness Day" event will held be from 10 a.m. to 2 p.m. at more than 4,600 Walmart stores with pharmacies. Customers can visit these stores to get free health screenings and low-cost flu shots. Exploding Kittens Inc. recalled 11,235 units of safety goggles sold with Throw Throw Burrito Extreme Going Pro Edition Dodgeball Card Game sets for concerns of laceration hazard if shattered. These include 735 units sold in Canada, a statement published by the U.S. Consumer Product Safety Commission said.
Follow RTT
>